Skip to main content
. 2017 Nov;23(11):1826–1833. doi: 10.3201/eid2311.170998

Table 2. Potential predictors of Mycoplasma genitalium infection among heterosexual men and women seen at Melbourne Sexual Health Centre who reported sexual contact with an M. genitalium–infected partner, Melbourne, Victoria, Australia, August 2008–July 2016*.

Characteristic No. Infected, no. (%) Not infected, no. (%) Unadjusted OR (95% CI) p value aOR† (95% CI) p value
Total
265






Age of sex partner, y‡
>27 141 53 (37.6) 88 (62.4) 1.0
<27
124
53 (42.7)
71 (57.3)
0.81 (0.49–1.32)
0.393


Sex
M 126 39 (31.0) 87 (69.0) 1.0 1.0
F
139
67 (48.2)
72 (51.8)
2.08 (1.25–3.43)
0.004
2.18 (1.28–3.71)
0.004
No. of sex partners in preceding 3 mo
1 126 59 (46.8) 67 (53.2) 1.0
>2
136
45 (33.1)
91 (66.9)
0.56 (0.34–0.93)
0.024


Nature of relationship with the notifying partner
Casual 64 17 (26.6) 47 (73.4) 1.0 1.0
Regular
194
86 (44.3)
108 (55.7)
2.20 (1.18–4.10)
0.013
2.13 (1.09–4.14)
0.026
Condom use with notifying partner in preceding 3 mo
100% 21 5 (23.8) 16 (76.2) 1.0 1.0
<100%
231
97 (42.0)
134 (58.0)
2.32 (0.13–1.27)
0.113
2.72 (0.93–7.91)
0.066
Symptoms in men§
No 99 25 (25.3) 74 (74.7) 1.0
Yes
21
11 (52.4)
10 (47.6)
3.26 (1.24–8.58)
0.017


Symptoms in women¶
No 93 45 (48.4) 48 (51.6) 1.0
Yes 24 14 (58.3) 10 (41.7) 1.49 (0.60–3.70) 0.387

*Bold text indicates a statistically significant association (p<0.05). Up to 7% of participants have missing data for some variables. aOR, adjusted odds ratio; MSM, men who have sex with men; OR, odds ratio.
†Adjusted for sex, nature of relationship with notifying partner, and reported condom use (100% vs. <100%).
‡The median age across all female, heterosexual male, and MSM contacts was 27 years.
§Discharge, dysuria, or urethral irritation; 6 men with urethral chlamydia excluded. In the combined heterosexual population symptoms were not significantly associated with infection and were not included in the multivariate model.
¶Vaginal discharge, dysuria, abnormal bleeding, or lower abdominal pain; 22 women with candidiasis, bacterial vaginosis, chlamydia, or urinary tract infections excluded.